Gastrointestinal Infections

Top Story

Dried blood spot tests practical for HCV screening in developing countries

Dried blood spot tests practical for HCV screening in developing countries
October 18, 2017

Researchers determined the prevalence and characteristics of hepatitis C viremia in the Democratic Republic of the Congo using dried blood spot viral load testing, according to a recently published study. Based on crude population estimates from 2016, the researchers expect 100,000 to 200,000 adults aged 40 years or older to be actively infected and eligible for treatment.

The Democratic Republic of the Congo is one of the largest countries in Africa and has limited infrastructure, so the diagnosis and treatment of HIV is challenging. In order to reach people living with HIV in rural areas, the AIDS Control Program transports dried blood spot samples from across the country to several central laboratories, where HIV viral load testing is performed,” Jonathan B. Parr, MD, MPH, from the University of North Carolina School of Medicine, told Healio.com/Hepatology. “We wanted to find a way to use this existing laboratory infrastructure to support the diagnosis and treatment of viral hepatitis.

Meeting News

Dose-escalation in IBD after CDI does not increase adverse outcomes risk

October 17, 2017
ORLANDO — Initiating immunosuppressive medication following treatment for Clostridium difficile infection was not correlated with adverse clinical outcomes in…
Pharmacology Consult

The changing HCV treatment cascade

Infectious Disease News, October 2017
Jocelyn Mason, PharmD; Kimberly D. Boeser, PharmD, MPH, BCPS, AQ-ID
Management of hepatitis C virus infection has drastically changed over the past 20 years — and even more so in the past 10 years — as a direct result of the…
At Issue

Should all food be irradiated?

Infectious Disease News, October 2017
The FDA has been evaluating the process of food irradiation for decades and has found it to be safe. However, although the FDA has approved the process for numerous
More Headlines »
CME CNE CPE

Familial Chylomicronemia Syndrome: Cause, Effect, and Solutions to Improve Patients' Quality-of-Life

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Pancreas Foundation.

Familial chylomicronemia syndrome (FCS) is a rare and potentially life-threatening genetic disease. The clinical…
More »
Meeting News

Antibiotics for dental procedures linked to C. difficile infection

October 6, 2017
SAN DIEGO — Researchers in Minnesota identified a potentially overlooked source of Clostridium difficile
More »
Resource Centers
IDWeek

IDWeek

Video
Meeting News Coverage

VIDEO: Systemic antibiotics increase C. difficile recurrence risk threefold

June 14, 2016
More »
Advertisement
Advertisement